{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:00:15Z","timestamp":1788210015218,"version":"build-2803163510"},"reference-count":29,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"DOI":"10.1210\/jc.2009-0747","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T22:15:11Z","timestamp":1251843311000},"page":"3700-3707","source":"Crossref","is-referenced-by-count":223,"title":["Thyroid-Associated Ophthalmopathy after Treatment for Graves\u2019 Hyperthyroidism with Antithyroid Drugs or Iodine-131"],"prefix":"10.1210","volume":"94","author":[{"given":"Frank","family":"Tra\u0308isk","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences (L.T., F.T.), St. Erik Eye Hospital, Karolinska Institute, SE-112 82 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Tallstedt","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences (L.T., F.T.), St. Erik Eye Hospital, Karolinska Institute, SE-112 82 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Abraham-Nordling","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Division of Surgery (M.A.-N.), Danderyd Hospital, Karolinska Institute, SE-171 77 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Andersson","sequence":"additional","affiliation":[{"name":"Ophthalmology (T.A.), Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrud","family":"Berg","sequence":"additional","affiliation":[{"name":"Oncology (G.B.), Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Calissendorff","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (J.C.), Karolinska University Hospital, Karolinska Institute, SE-141 86 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Hallengren","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (B.H., M.L.), Malmoe University Hospital, SE-205 02 Malmoe, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavo","family":"Hedner","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (P.H.), Lund University Hospital, SE-221 85 Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Lantz","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (B.H., M.L.), Malmoe University Hospital, SE-205 02 Malmoe, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Nystro\u0308m","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (E.N.), Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Ponjavic","sequence":"additional","affiliation":[{"name":"Ophthalmology (V.P.), Lund University Hospital, SE-221 85 Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Taube","sequence":"additional","affiliation":[{"name":"Department of Information Science (A.T.), University of Uppsala, SE-751 20 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"To\u0308rring","sequence":"additional","affiliation":[{"name":"Department of Clinical Research and Education, Karolinska Institute and Department of Internal Medicine, Division of Endocrinology, (O.T.), So\u0308dersjukhuset, SE-118 83 77 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go\u0308ran","family":"Wallin","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Division of Surgery (G.W.), Karolinska University Hospital, Karolinska Institute, SE-141 86 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"A\u030asman","sequence":"additional","affiliation":[{"name":"Ophthalmology (P.A\u030a.), Malmoe University Hospital, SE-205 02 Malmoe, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go\u0308ran","family":"Lundell","sequence":"additional","affiliation":[{"name":"Department of Oncology, Radiumhemmet (G.L.), Karolinska University Hospital, Karolinska Institute, SE-141 86 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Thyroid Study Group of TT 96","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114023608400_R1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279.x","article-title":"Radioiodine therapy for Graves\u2019 disease and the effect on ophthalmopathy\u2014a systematic review.","volume":"69","author":"Acharya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114023608400_R2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The Thyroid Study Group.","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114023608400_R3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1755-3768.1972.tb06615.x","article-title":"Hypothyroidism in progressive ophthalmopathy of Graves\u2019 disease.","volume":"50","author":"Almqvist","year":"1972","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"key\n\t\t\t\t2019041114023608400_R4","first-page":"179","article-title":"Observations on progression periods in Graves\u2019 ophthalmopathy","author":"Sjo\u0308berg","year":"1989","journal-title":"Acta Endocrinol (Copenh) 121(Suppl 2):"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041114023608400_R5","first-page":"132","article-title":"Importance of TSH receptor activation in the development of severe endocrine ophthalmopathy","volume":"121","author":"Karlsson","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key\n\t\t\t\t2019041114023608400_R6","first-page":"542","article-title":"The incidence of ophthalmopathy after radioiodine therapy for Graves\u2019 disease: prognostic factors and the role of methimazole.","volume":"79","author":"Kung","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jcem.80.2.7852485","article-title":"Radioiodine therapy does not aggravate Graves\u2019 ophthalmopathy.","volume":"80","author":"Gorman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1530\/eje.0.1300494","article-title":"Does early administration of thyroxine reduce the development of Graves\u2019 ophthalmopathy after radioiodine treatment?","volume":"130","author":"Tallstedt","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114023608400_R9","first-page":"2986","article-title":"Graves\u2019 hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine\u2014a prospective, randomized study. Thyroid Study Group.","volume":"81","author":"To\u0308rring","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R10","first-page":"228","article-title":"Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.","volume":"37","author":"Berg","year":"1996","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041114023608400_R11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy.","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114023608400_R12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/jcem-62-4-773","article-title":"Methimazole, but not Betamethasone, prevents iodine-131 treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves\u2019 disease.","volume":"62","author":"Gamstedt","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114023608400_R14","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R15","first-page":"2352","article-title":"Stimulation of adipogenesis, peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3), and thyrotropin receptor by PPAR\u03b3 agonist in human orbital preadipocyte fibroblasts.","volume":"87","author":"Valyasevi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R16","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves\u2019 disease is mediated through the insulin-like growth factor I receptor pathway.","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019041114023608400_R17","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor.","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves\u2019 disease.","volume":"316","author":"To\u0308tterman","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114023608400_R19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bmj.288.6416.518","article-title":"Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression.","volume":"288","author":"Weetman","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t2019041114023608400_R20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1210\/jcem-51-2-298","article-title":"Effects of antithyroid drugs on lymphocyte function in vitro.","volume":"51","author":"Hallengren","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198008073030603","article-title":"Carbimazole and the autoimmune response in Graves\u2019 disease.","volume":"303","author":"McGregor","year":"1980","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114023608400_R22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus Statement of the European Group on Graves\u2019 Orbitopathy (EUGOGO) on Management of Graves\u2019 Orbitopathy.","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041114023608400_R23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus Statement of the European Group on Graves\u2019 Orbitopathy (EUGOGO) on Management of Graves\u2019 Orbitopathy","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114023608400_R24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves\u2019 ophthalmopathy after radioiodine therapy for hyperthyroidism.","volume":"321","author":"Bartalena","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114023608400_R25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-2006-924321","article-title":"Radioiodine therapy of Graves\u2019 hyperthyroidism in patients without pre-existing ophthalmopathy: can glucocorticoids prevent the development of new ophthalmopathy?","volume":"114","author":"Dederichs","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t2019041114023608400_R26","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves\u2019 ophthalmopathy.","volume":"90","author":"Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2967\/jnumed.107.049437","article-title":"Radioiodine therapy and Graves\u2019 ophthalmopathy.","volume":"49","author":"Sisson","year":"2008","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041114023608400_R28","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease.","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114023608400_R29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ncpendmet0497","article-title":"Management of Graves\u2019 ophthalmopathy.","volume":"3","author":"Wiersinga","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/10\/3700\/9057761\/jcem3700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T05:31:36Z","timestamp":1558503096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/10\/3700\/2596626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-0747","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1165783.628839","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}